Clarithromycin Use and Risk of Death in Patients with Ischemic Heart Disease

被引:17
作者
Andersen, Soren Skott [1 ]
Hansen, Morten Lock [1 ]
Norgaard, Mette Lykke [1 ]
Folke, Fredrik [1 ]
Fosbol, Emil Loldrup [1 ]
Abildstrom, Steen Z. [2 ,4 ]
Raunso, Jakob [1 ]
Madsen, Mette [4 ]
Kober, Lars [3 ]
Gislason, Gunnar H. [1 ]
Torp-Pedersen, Christian [1 ]
机构
[1] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
[2] Glostrup Cty Hosp, Dept Cardiol, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Rigshosp, Ctr Heart, Dept Cardiol, Copenhagen, Denmark
[4] Univ Copenhagen, Dept Publ Hlth Res, Copenhagen, Denmark
关键词
Ischemic heart disease; Clarithromycin; Chlamydia pneumoniae; ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; CHLAMYDIA-PNEUMONIAE INFECTION; SECONDARY PREVENTION; ANTIBIOTIC-TREATMENT; SHORT-TERM; AZITHROMYCIN; MORTALITY; METAANALYSIS; EVENTS;
D O I
10.1159/000315394
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To examine whether treatment with clarithromycin was associated with an increased risk of death in patients with preexisting ischemic heart disease (IHD). Methods: Employing nationwide registers, all patients with IHD events from 1997 to 2007 who subsequently claimed prescriptions for dual antibiotic treatment for eradication treatment were identified. The primary endpoint was all-cause mortality. Results: The study included 214,330 individuals with IHD; 5,265 (2.5 %) of these claimed prescriptions for dual antibiotics. Compared with IHD patients not undergoing eradication therapy, no increase in the risk of all-cause mortality was demonstrated (HR 1.02; 95% CI 0.84-1.23, p = 0.87) after 5 years. Conclusions: The use of clarithromycin in the setting of eradication treatment for Helicobacter pylori in patients with IHD was not associated with an increased risk of death. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:89 / 97
页数:9
相关论文
共 22 条
[1]  
Ables AZ, 2007, AM FAM PHYSICIAN, V75, P351
[2]   Effects of antibiotic therapy on outcomes of patients with coronary artery disease - A meta-analysis of randomized controlled trials [J].
Andraws, R ;
Berger, JS ;
Brown, DL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (21) :2641-2647
[3]   Evidence for persistent Chlamydia pneumoniae infection of human coronary atheromas [J].
Borel, Nicole ;
Summersgill, James T. ;
Mukhopadhyay, Sanghamitra ;
Miller, Richard D. ;
Ramirez, Julio A. ;
Pospischil, Andreas .
ATHEROSCLEROSIS, 2008, 199 (01) :154-161
[4]   Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Grayston, JT ;
Muhlestein, B ;
Giugliano, RP ;
Cairns, R ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16) :1646-1654
[5]   Increased risk of mortality following antibiotic treatment in patients with coronary artery disease? [J].
Cercek, Bojan .
CARDIOLOGY, 2008, 111 (04) :277-279
[6]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[7]   Antibiotics for secondary prevention of coronary artery disease: An ACES hypothesis but we need to PROVE IT [J].
Gelfand, EV ;
Cannon, CP .
AMERICAN HEART JOURNAL, 2004, 147 (02) :202-209
[8]   In vitro susceptibility and eradication of chlamydia pneumoniae cardiovascular strains from coronary artery endothelium and smooth muscle cells [J].
Gieffers, J ;
Solbach, W ;
Maass, M .
CARDIOVASCULAR DRUGS AND THERAPY, 2001, 15 (03) :259-262
[9]  
Gieffers J, 2001, CIRCULATION, V103, P351
[10]   Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction [J].
Gislason, GH ;
Rasmussen, JN ;
Abildstrom, SZ ;
Gadsboll, N ;
Buch, P ;
Friberg, J ;
Rasmussen, S ;
Kober, L ;
Stender, S ;
Madsen, M ;
Torp-Pedersen, C .
EUROPEAN HEART JOURNAL, 2006, 27 (10) :1153-1158